Is TMS Therapy Safe for Treatment-Resistant Depression? What Patients in Bend, OR Should Know

When medications have not provided the relief you need from depression, exploring new treatment options can feel both hopeful and uncertain. Transcranial Magnetic Stimulation (TMS) has become a widely recognized option for treatment-resistant depression, and one of the most common questions patients ask their providers is whether TMS therapy is safe. This is a reasonable and important question, and understanding what the research shows can help you make a more informed decision about your care.

At Path to Awareness, serving patients in Bend, OR and Medford, OR, we believe that education is a critical part of any treatment journey. This guide breaks down what TMS is, how it works, and what current evidence tells us about its safety profile so you can have a more productive conversation with your healthcare provider.

What Is TMS Therapy and How Does It Work?

TMS is a non-invasive brain stimulation technique that uses focused magnetic pulses to stimulate nerve cells in specific areas of the brain associated with mood regulation. During a session, an electromagnetic coil is placed against the scalp near the forehead. The device delivers brief magnetic pulses that pass through the skull and activate targeted regions of the brain, particularly the prefrontal cortex, which is often underactive in individuals living with depression.

Unlike some other interventions for depression, TMS does not require anesthesia, sedation, or any surgical procedure. Patients remain awake and alert throughout each session, which typically lasts between 20 and 40 minutes depending on the treatment protocol. Most treatment courses involve sessions five days a week over a period of approximately six to eight weeks, though individual plans may vary based on clinical evaluation.

Who Is TMS Designed to Help?

TMS received clearance from the U.S. Food and Drug Administration (FDA) for the treatment of major depressive disorder in adults who have not responded adequately to prior antidepressant medications. This condition is commonly referred to as treatment-resistant depression, or TRD. An estimated one-third of individuals with major depressive disorder may not achieve adequate relief from standard antidepressant therapy alone, making alternative approaches like TMS an important consideration in their treatment plan.

Is TMS Therapy Safe? What Clinical Evidence Shows

The question of whether TMS therapy is safe has been studied extensively over the past two decades. TMS has been the subject of numerous clinical trials, peer-reviewed studies, and real-world outcome analyses. The collective body of evidence supports TMS as a well-tolerated treatment with a favorable safety profile when administered by trained professionals.

Several key points stand out from the available research:

FDA clearance: TMS was first cleared by the FDA for treatment-resistant depression in 2008 and has since undergone continued review and expanded approval, reflecting a strong body of supporting safety and efficacy data.
Non-systemic treatment: Because TMS targets the brain directly using magnetic fields rather than circulating through the bloodstream, it does not carry the systemic side effects commonly associated with antidepressant medications, such as weight gain, sexual dysfunction, or gastrointestinal discomfort.
No sedation or anesthesia required: Patients do not need to be sedated, which eliminates the risks associated with general anesthesia and allows individuals to drive themselves to and from appointments.
Low risk of serious adverse events: Across clinical trials and large-scale studies, serious adverse events from TMS have been exceedingly rare when protocols are followed appropriately.

While no medical treatment is entirely without risk, the overall safety data for TMS has been consistently encouraging, which is one reason it has become an increasingly mainstream option for adults living with treatment-resistant depression in 2026.

Common Side Effects of TMS and What to Expect

Understanding potential side effects is an important part of evaluating any treatment. Most side effects associated with TMS are mild and tend to diminish over the course of treatment as patients become accustomed to the stimulation.

Mild and Common Side Effects

Scalp discomfort or tingling: The most frequently reported side effect is a tapping or tingling sensation at the site where the coil is placed. This is typically mild and often decreases after the first few sessions.
Headache: Some patients experience mild headaches during or after treatment, which may be managed with over-the-counter pain relief as recommended by a provider.
Lightheadedness: Occasional lightheadedness has been reported, though it is generally short-lived.

Rare and Serious Side Effects

The most serious potential risk associated with TMS is seizure. However, this is considered extremely rare and occurs at a rate comparable to that of many commonly prescribed antidepressant medications. Providers conduct thorough screening before treatment to identify any factors that may increase seizure risk, such as a history of epilepsy or certain neurological conditions. When proper screening and safety protocols are in place, the likelihood of a serious adverse event is very low.

It is also worth noting that TMS does not cause the memory loss or cognitive side effects that may be associated with electroconvulsive therapy (ECT), another brain stimulation technique sometimes used for severe depression. Many patients appreciate that they can return to their normal daily activities, including work, immediately after a TMS session.

How TMS Compares to Other Treatment Options for Depression

For patients in Bend and Medford who are weighing their options, it can be helpful to understand how TMS fits into the broader landscape of depression treatment.

TMS vs. Antidepressant Medications

Antidepressant medications remain a first-line treatment for depression, and they are effective for many individuals. However, for those with treatment-resistant depression who have tried two or more medications without adequate improvement, the likelihood of achieving remission with an additional medication attempt decreases with each successive trial. TMS offers a different mechanism of action that does not depend on systemic medication, making it a valuable alternative for patients who have not responded to pharmacotherapy or who experience intolerable medication side effects.

TMS vs. Electroconvulsive Therapy (ECT)

ECT is one of the oldest and most studied brain stimulation therapies for severe depression. While effective, ECT requires general anesthesia and may cause short-term memory loss and cognitive effects. TMS, by contrast, does not require anesthesia, does not produce the cognitive side effects associated with ECT, and can be administered in an outpatient setting. For many patients, this makes TMS a more accessible and less disruptive option.

Effectiveness at a Glance

Clinical data and real-world outcomes suggest that approximately 50 to 60 percent of patients with treatment-resistant depression who undergo TMS may experience a meaningful reduction in symptoms. Of those, roughly one-third may achieve full remission, meaning their depressive symptoms resolve entirely. While results vary from person to person and no treatment guarantees a specific outcome, these response rates represent a meaningful option for individuals who have struggled to find relief through other methods.

What Patients in Bend and Medford Should Know Before Starting TMS

If you are considering TMS for treatment-resistant depression, there are several practical considerations that may help guide your next steps.

Consultation and Screening

Before beginning treatment, a qualified provider will conduct a comprehensive evaluation to determine whether TMS is appropriate for your individual situation. This typically includes a review of your medical history, current medications, and prior treatment responses. Not everyone is a candidate for TMS, and certain conditions, such as the presence of metallic implants near the treatment area, may preclude its use. A thorough screening process helps ensure that the treatment is both safe and suitable for each patient.

Insurance Coverage for TMS

TMS for treatment-resistant depression is often covered by insurance. Path to Awareness accepts a wide range of insurance plans, including Aetna, BCBS, Cigna, United Healthcare, Tri-Care, Humana, Medicare, Optum, Medicaid, and Oregon Health Plan (OHP). Coverage details may vary by plan, so contacting the clinic directly is the best way to confirm your specific benefits.

What a Typical Treatment Course Looks Like

A standard TMS treatment course generally involves daily sessions, five days per week, for approximately six to eight weeks. Each session is conducted in an outpatient setting, meaning there is no hospital stay required. Patients can typically resume their normal activities immediately following each appointment, including driving and returning to work. This outpatient convenience is one of the reasons many patients find TMS to be a practical choice for managing treatment-resistant depression.

Making an Informed Decision About TMS

Deciding whether to pursue any new treatment for depression is a deeply personal choice, and it is one that should be made in partnership with a qualified healthcare provider who understands your unique history. When patients ask whether TMS therapy is safe, the evidence available in 2026 supports it as a well-studied, FDA-cleared treatment with a favorable safety profile, minimal systemic side effects, and a growing body of clinical and real-world data demonstrating its effectiveness for treatment-resistant depression.

No treatment is right for every individual, and outcomes vary. However, for patients who have not found adequate relief through medication alone, TMS represents a meaningful option that has helped many people experience improvement in their depressive symptoms.

If you are living in Bend, Medford, or the surrounding areas and would like to learn more about whether TMS may be appropriate for your situation, Path to Awareness is here to help. We encourage you to reach out to our team to schedule a consultation and discuss your treatment options with a knowledgeable provider who can answer your questions and help you take the next step toward relief.